Generali Investments Management’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.26M Sell
15,400
-43,354
-74% -$7.86M 0.49% 48
2026
Q1
$8.64M Buy
58,754
+38,021
+183% +$6.18M 2.01% 10
2025
Q4
$4.04M Buy
20,733
+9,378
+83% +$2.23M 0.81% 25
2025
Q3
$3.19M Buy
11,355
+552
+5% +$141K 0.67% 32
2025
Q2
$2.36M Buy
10,803
+5,038
+87% +$814K 0.53% 53
2025
Q1
$806K Sell
5,765
-17,387
-75% -$2.83M 0.23% 84
2024
Q4
$3.86M Buy
+23,152
New +$4.11M 1% 24

Other funds holding ORCL

Generali Investments Management's ORCL Position: Q2 2026 in Review

Generali Investments Management reduced its Oracle (ORCL) stake by 74% in Q2 2026, selling an estimated $7.86M and leaving 15,400 shares worth $2.26M. The position accounts for 0.49% of the portfolio, ranked #48.

Generali Investments Management first reported a position in ORCL in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.64M in Q1 2026. 1,460 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Generali Investments Management held 15,400 shares of Oracle worth $2.26M as of Q2 2026.
  • Generali Investments Management sold 43,354 Oracle shares in Q2 2026, an estimated $7.86M.
  • Oracle made up 0.49% of Generali Investments Management's portfolio in Q2 2026, its #48 holding.
  • Generali Investments Management first reported a position in Oracle in Q4 2024 and has held it in 7 quarters since.
  • Generali Investments Management's Oracle position peaked at $8.64M in Q1 2026.
  • 1,460 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Generali Investments Management's 13F filing for Q2 2026, filed 10 Jul 2026.